[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617412":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":26,"locations":26,"responsibleParty":31,"collaborators":26,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":37,"sex":43,"minAge":44,"maxAge":26,"enrollmentInfo":45,"targetDuration":26,"studyType":48,"phases":49,"briefSummary":51,"conditions":52,"keywords":26,"overallStatus":56,"whyStopped":26,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":26},{"fullName":5,"class":6},"Hadassah Medical Organization","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Control Group","PLACEBO_COMPARATOR","Participants in this arm will receive 5 mL of normal saline infused through the internal cervical os immediately before office hysteroscopy.",[13],"Other: Saline (0.9% NaCl)",{"label":15,"type":16,"description":17,"interventionNames":18},"Lidocaine Group","EXPERIMENTAL","Participants in this arm will receive 5 mL of 2% lidocaine infused through the internal cervical os immediately before office hysteroscopy.",[19],"Drug: Lidocaine %2 ampoule",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Lidocaine %2 ampoule","A 5 mL dose of 2% lidocaine solution will be infused slowly through the internal os using the hysteroscope before the start of uterine cavity distension.",[15],null,{"type":6,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Saline (0.9% NaCl)","A 5 mL dose of sterile normal saline will be infused slowly through the internal os using the same technique as in the intervention arm, immediately before cavity distension.",[9],{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"SPONSOR_INVESTIGATOR","YAARA TABIB","Principal Investigator, Obstetrics and Gynecology Research Unit, Hadassah Medical Center","100617412","targeted-lidocaine-infusion-for-pain-reduction-in-office-hysteroscopy-100617412",false,"NCT07318285","Targeted Lidocaine Infusion for Pain Reduction in Office Hysteroscopy","A Modified Technique of Target Lidocaine Infusion for Pain Control in Office Hysteroscopy: A Double-Blind Randomized Controlled","OPTILID","Inclusion Criteria:\n\n* Age \\> 18\n* Referred for outpatient diagnostic or operative (see-and-treat) hysteroscopy\n* Able and willing to provide written informed consent\n\nExclusion Criteria:\n\n* Pregnancy\n* Active pelvic inflammatory disease or cervicitis\n* Inability to consent\n* Anti-psychotic drugs usage\n* Previews cervical surgery (i.e., conization).\n* Any contraindication for office hysteroscopy- cervical malignancy, profuse uterine bleeding, invisible external os, recent uterine perforation.\n* Known allergy or hypersensitivity to Lidocaine","FEMALE","18 Years",{"count":46,"type":47},208,"ESTIMATED","INTERVENTIONAL",[50],"NA","The goal of this study is to find out whether a small amount of lidocaine (a common local anesthetic) can reduce pain during office hysteroscopy - a procedure used to look inside the uterus. The study will compare lidocaine to saline (salt water) to see which one helps more with pain relief.\n\nParticipants will:\n\n1. Receive either lidocaine or saline gently applied inside the cervix right before the procedure\n2. Undergo the hysteroscopy as planned\n3. Be asked to rate their pain and satisfaction after the procedure\n\nLidocaine is commonly and safely used in dental and gynecological procedures. Participation is voluntary, and the procedure itself will not change.",[53,54,55],"Hysteroscopy \u002F Methods","Lidocaine Infusion","Placebo - Control","NOT_YET_RECRUITING","2025-12-28",{"date":59,"type":60},"2026-01-05","ACTUAL",{"date":62,"type":47},"2026-02-01",{"date":64,"type":47},"2029-12-30",{"name":33,"class":6}]